Promis Neurosciences (PMN) vs PMV Pharmaceuticals, Inc. (PMVP)

Promis Neurosciences and PMV Pharmaceuticals, Inc. are both Biotechnology companies. Promis Neurosciences and PMV Pharmaceuticals, Inc. are of similar size ($103.8M and $100.8M). Across the 8 metrics below, PMV Pharmaceuticals, Inc. leads on 5 and Promis Neurosciences on 3.

Valuation

Metric PMN PMVP Biotechnology median
P/E n/m n/m 7.88
P/S 46,834.02 n/m 11.47
P/B 2.09 0.99 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 0.10 0.74
EV/Sales 24,347.61 n/m 10.73
Earnings yield (112.60%) (106.77%) (28.84%)
Free cash flow yield (40.87%) (100.36%) (23.03%)

Profitability

Metric PMN PMVP Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (172.30%) (70.93%) (57.72%)
Return on assets (127.57%) (64.04%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric PMN PMVP Biotechnology median
Revenue growth (TTM) 450.00% — 5.64%
EPS growth (last fiscal year) (922.18%) (29.82%) —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PMN PMVP Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.85 7.70 4.73
Net debt to EBITDA 0.15 1.27 0.96

Dividend

Metric PMN PMVP Biotechnology median
Dividend yield — — 2.10%
Payout ratio — 0.00 0.00

Size

Metric PMN PMVP Biotechnology median
Market cap 103.76m 100.81m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack